Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03792633 · OUTCOME

Number of Subjects With Event-Free Survival in Patients With Poor Response to Prior B Cell Directed Engineered Cell Therapy 1 Year After Treatment.

Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL · Source last updated 2025-06-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of subject
Interval / dispersion
95% Confidence Interval
Time frame
1 year

What was measured

Time from infusion to the first of event or censoring Events = Relapse, No Response (including CR/CRi without B Cell Aplasia), or Death; Censoring =Initiation of New Anticancer Therapy, Last Day of Follow-up/EOS; whichever occurs first.

Groups in this outcome

Cohort B

Poor Response to Prior B Cell Directed Engineered cell therapy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cohort B48

Reported measurements

Source class 1
Values in percentage of subject · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Cohort B62Not reported4978.4Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        49
        upper Limit
        78.4
        value
        62
denoms
  1. counts
    1. group Id
      OG000
      value
      48
    units
    Participants
description
Time from infusion to the first of event or censoring Events = Relapse, No Response (including CR/CRi without B Cell Aplasia), or Death; Censoring =Initiation of New Anticancer Therapy, Last Day of Follow-up/EOS; whichever occurs first.
dispersion Type
95% Confidence Interval
groups
  1. description
    Poor Response to Prior B Cell Directed Engineered cell therapy
    id
    OG000
    title
    Cohort B
param Type
NUMBER
reporting Status
POSTED
time Frame
1 year
title
Number of Subjects With Event-Free Survival in Patients With Poor Response to Prior B Cell Directed Engineered Cell Therapy 1 Year After Treatment.
type
PRIMARY
unit Of Measure
percentage of subject

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice